FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2475338118> ?p ?o ?g. }

• W2475338118 endingPage "515" @default.
• W2475338118 startingPage "510" @default.
• W2475338118 abstract "Ankylosing spondylitis (AS) is an immune-mediated inflammatory arthritis and enthesitis involving the spine and peripheral joints. In recent years, specific antagonist of tumor necrosis factor (anti-TNFα, etanercept) 50 mg weekly therapy has rapidly gained popularity for the treatment of AS. However, the dose of etanercept has not been determined in Asian, particularly Chinese populations. The purpose of the study was to evaluate the efficacy and safety of dose reduction of etanercept (50 mg/week in 4 weeks followed by 25 mg/week in 8 weeks) in the treatment of AS with synovitis of the hip, as against the conventional dose (50 mg/week in 12 weeks) in a Chinese population. Forty-three Chinese AS patients with synovitis of the hip were involved in this study. Seventeen of them were randomized to receive conventional dose of etanercept treatment and 26 were given a dose reduction regimen for 12 weeks. The primary efficacy endpoint was disease activity of response for AS at week 12, including Bath AS Disease Activity Index (BASDAI), the serum erythrocyte sediment rate (ESR), C-reactive protein (CRP), and assessment of synovitis of the hip by ultrasonography. At 12 weeks, all of the patients had responses to some extent and the efficacy variables improved significantly over time, but not between treatment groups. Nine patients experienced at least one adverse event (generally, infections and injection site reactions), most of them mild or moderate. In sum, the dose reduction of etanercept regimen in the 12-week AS treatment was confirmed as a safe and effective therapy as the conventional dose was given." @default.
• W2475338118 created "2016-07-22" @default.
• W2475338118 creator A5004444053 @default.
• W2475338118 creator A5021825380 @default.
• W2475338118 creator A5061769699 @default.
• W2475338118 creator A5068947466 @default.
• W2475338118 creator A5069516330 @default.
• W2475338118 creator A5079894628 @default.
• W2475338118 creator A5084985646 @default.
• W2475338118 date "2016-07-07" @default.
• W2475338118 modified "2023-10-18" @default.
• W2475338118 title "Dose reduction of recombinant human tumor necrosis factor inhibitors (etanercept) can be effective in ankylosing spondylitis patients with synovitis of the hip in a Chinese population" @default.
• W2475338118 cites W1978435833 @default.
• W2475338118 cites W1985504485 @default.
• W2475338118 cites W2002814457 @default.
• W2475338118 cites W2004375912 @default.
• W2475338118 cites W2010090350 @default.
• W2475338118 cites W2018410379 @default.
• W2475338118 cites W2028433937 @default.
• W2475338118 cites W2049161311 @default.
• W2475338118 cites W207060084 @default.
• W2475338118 cites W2116244882 @default.
• W2475338118 cites W2125623644 @default.
• W2475338118 cites W2127756765 @default.
• W2475338118 cites W2128918690 @default.
• W2475338118 cites W2129664075 @default.
• W2475338118 cites W2134280423 @default.
• W2475338118 cites W2138766095 @default.
• W2475338118 cites W2150155006 @default.
• W2475338118 cites W2153919578 @default.
• W2475338118 cites W2163493960 @default.
• W2475338118 cites W3135506742 @default.
• W2475338118 cites W3214717203 @default.
• W2475338118 cites W4210974969 @default.
• W2475338118 cites W460059175 @default.
• W2475338118 doi "https://doi.org/10.1177/0394632016656013" @default.
• W2475338118 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5806770" @default.
• W2475338118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27381286" @default.
• W2475338118 hasPublicationYear "2016" @default.
• W2475338118 type Work @default.
• W2475338118 sameAs 2475338118 @default.
• W2475338118 citedByCount "15" @default.
• W2475338118 countsByYear W24753381182019 @default.
• W2475338118 countsByYear W24753381182020 @default.
• W2475338118 countsByYear W24753381182021 @default.
• W2475338118 countsByYear W24753381182022 @default.
• W2475338118 countsByYear W24753381182023 @default.
• W2475338118 crossrefType "journal-article" @default.
• W2475338118 hasAuthorship W2475338118A5004444053 @default.
• W2475338118 hasAuthorship W2475338118A5021825380 @default.
• W2475338118 hasAuthorship W2475338118A5061769699 @default.
• W2475338118 hasAuthorship W2475338118A5068947466 @default.
• W2475338118 hasAuthorship W2475338118A5069516330 @default.
• W2475338118 hasAuthorship W2475338118A5079894628 @default.
• W2475338118 hasAuthorship W2475338118A5084985646 @default.
• W2475338118 hasBestOaLocation W24753381181 @default.
• W2475338118 hasConcept C126322002 @default.
• W2475338118 hasConcept C141071460 @default.
• W2475338118 hasConcept C168563851 @default.
• W2475338118 hasConcept C17991360 @default.
• W2475338118 hasConcept C197934379 @default.
• W2475338118 hasConcept C203092338 @default.
• W2475338118 hasConcept C2776260265 @default.
• W2475338118 hasConcept C2777077863 @default.
• W2475338118 hasConcept C2777226972 @default.
• W2475338118 hasConcept C2777402515 @default.
• W2475338118 hasConcept C2777453003 @default.
• W2475338118 hasConcept C2779244835 @default.
• W2475338118 hasConcept C2779650986 @default.
• W2475338118 hasConcept C2780131103 @default.
• W2475338118 hasConcept C2781413609 @default.
• W2475338118 hasConcept C2908647359 @default.
• W2475338118 hasConcept C71924100 @default.
• W2475338118 hasConcept C90924648 @default.
• W2475338118 hasConcept C99454951 @default.
• W2475338118 hasConceptScore W2475338118C126322002 @default.
• W2475338118 hasConceptScore W2475338118C141071460 @default.
• W2475338118 hasConceptScore W2475338118C168563851 @default.
• W2475338118 hasConceptScore W2475338118C17991360 @default.
• W2475338118 hasConceptScore W2475338118C197934379 @default.
• W2475338118 hasConceptScore W2475338118C203092338 @default.
• W2475338118 hasConceptScore W2475338118C2776260265 @default.
• W2475338118 hasConceptScore W2475338118C2777077863 @default.
• W2475338118 hasConceptScore W2475338118C2777226972 @default.
• W2475338118 hasConceptScore W2475338118C2777402515 @default.
• W2475338118 hasConceptScore W2475338118C2777453003 @default.
• W2475338118 hasConceptScore W2475338118C2779244835 @default.
• W2475338118 hasConceptScore W2475338118C2779650986 @default.
• W2475338118 hasConceptScore W2475338118C2780131103 @default.
• W2475338118 hasConceptScore W2475338118C2781413609 @default.
• W2475338118 hasConceptScore W2475338118C2908647359 @default.
• W2475338118 hasConceptScore W2475338118C71924100 @default.
• W2475338118 hasConceptScore W2475338118C90924648 @default.
• W2475338118 hasConceptScore W2475338118C99454951 @default.
• W2475338118 hasIssue "3" @default.
• W2475338118 hasLocation W24753381181 @default.
• W2475338118 hasLocation W24753381182 @default.
• W2475338118 hasLocation W24753381183 @default.

• next